This trial is evaluating whether 8-h Afternoon-Evening Sleep will improve 11 primary outcomes and 4 secondary outcomes in patients with Parasomnias. Measurement will happen over the course of Subjective Alertness via VAS measurements taken at the end of the final night shift (night shift 3) in the intervention block will be compared between groups..
This trial requires 75 total participants across 2 different treatment groups
This trial involves 2 different treatments. 8-h Afternoon-Evening Sleep is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Hospitalizations for sleep disturbances tripled between the years 1982-1985 and 1992-1995. Most hospitalizations are not due to sleep deprivation. The number of sleep-related readmissions fell from 1992-1995, possibly due to heightened awareness of this problem in the medical community. Patients may be discharged sooner and they are less likely to need hospitalization when they are readmitted. Recent findings may have been affected by the development of the health maintenance organization system. The number of hospitalizations for sleep-related diagnoses (benign and non-benign sleep disorders) is low.
It is considered as any sleep-related event such as a parasomnia, hypersomnia or hypnagogia. Parasomnias were also reported by patients after aneurysmal subarachnoid hemorrhage. The sleep can present as hallucinations, illusions, auditory experiences during sleep, or sleep-paroxysmal movements. Parasomnias are related to REM sleep. We have established five types of parasomnias, which are classified as the following:\n1. Pregnancy-related:\n2. Paroxysmal non-rapid eye movement:\n3. Rapid eye movement (REM) sleep paralysis:\n4. Paresis-related:\n5.
There are a variety of possible causes of sleep-related problems, including sleep debt, daytime drowsiness, sleep-related breathing disturbances and low energy levels and there is strong evidence that circadian and sleep problems can interact. These can be primary or secondary. If these problems are related to a particular syndrome, it may be that the sleep disturbance is the primary event and that the other symptoms develop as a result. Parasomnias cannot be classified as a discrete entity because of the variability of such complaints and the difficulty in assessing the extent to which the sleep disturbance is the precipitant of the other symptoms.
Most cases of sleepwalking occur in early childhood; however, one case of parasomnia occurred in a 46-year-old man with a history of nocturnal enuresis and insomnia. In this case, the symptoms may be similar to those seen during daytime sleepwalking and can complicate differential diagnosis. Sleep walking can include sleep talking, and other sleep related non-rapid eye movement behavior.
Parasomnias tend to be treated by the patient's own doctors using a combination of behavioral therapy and medications. If the patient sees a mental health professional they will usually prescribe a more definitive behavioral intervention, while having a medication as a third-line treatment will be common. As more behavioral treatment options are tried they are either added or removed on a case-by-case basis depending on their benefit to the patient. Finally there is no one-size fit-all treatment to help with the symptoms of a patient with parasomnias. It is not possible to recommend one medication because there is not enough data on which medications are most effective.
Although often treated with antipsychotic medication, approximately one third of patients did not respond and had long-term or permanent sequelae due to their sleep disorders.
While the number of treatments for individual sleep disorders has remained unchanged, some new treatments have been reported for parasomnias, including the use of melatonin (melatonin agonist) for idiopathic hypersomnia, and zonisamide for restless legs syndrome. While there is growing evidence that antidepressants can be used in sleep disorders, a large, well-designed clinical trial is needed to confirm that antidepressants are safe and effective for treating the underlying core problems of idiopathic hypersomnia and restless legs syndrome.
Parasomnias is a very common sleep disorder; however, the average age someone gets them is under 41 years. It is likely that older adults are more likely to have nocturnal enuresis and nighttime pain. Sleep disorder was the most common cause of insomnia. Older adults might have sleep disordered breathing, and younger adults might have sleep paralysis.
Results from a recent clinical trial of this study revealed the common side effects of 8-h afternoon-evening sleep in women. Subjects complained of various symptoms of headache, dizziness, irritability, dry mouth, and the like. In spite of insomnia or daytime drowsiness resulting in a fall in cognitive function, these symptoms in most cases did not impact work efficiency or social interactions. However, people experiencing these symptoms should keep in line with the advice they receive from a psychiatrist or medical doctor.
The poor quality of sleep, daytime sleepiness, and fatigue associated with parasomnias are known to reduce a person's Quality of Life. Recent findings found that the addition of a healthy 8-h period of sleep in the afternoon improves Quality of Life in those with parasomnias.
The current study has found no evidence to support a link between sleep disturbances and sleep-related accidents and injuries. It is possible that sleep-related injuries can occur during daytime, after one has become sleepy, and may, therefore, have different pathophysiologies.
Sleep is not typically used in combination with other treatments in patients with somnipathy. However, in the presence of this condition, a daytime nap, which has been used extensively for several years, should not be ignored.